'Mad Money' host Jim Cramer previews what's to come in another week of earnings as the market makes another attempt to break past its highs.
's quarterly report will come out after the market closes and is expected to record $597 million in revenue and produce 20 cents of earnings per share, according to FactSet.reports earnings after the closing bell. The entertainment conglomerate is expected to turn in 95 cents of profit per share on more than $19 billion in revenue, which would be 34% higher than the year-ago quarter. Disney Plus, the company's new streaming service, is slated to launch on Tuesday.
also reports at the end of the trading day. Analysts are expecting the video game producer to record $1.70 of profit per share on $926 million in revenue., a global automotive supplier of mobility technology, releases earnings in the morning. Wall Street estimates are $1.77 earnings per share and nearly $12.3 billion in revenue. Cramer expects the company to give investors a better read on the slumping auto industry.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Everything Jim Cramer said about the stock market on 'Mad Money,' including stock picks, Columbia Sportswear CEO, Fed and China chatter, SmartiesCNBC's Jim Cramer reveals stocks worth buying after Thursday's market decline, breaks down emerging Fed and China trade worries, and sits down with top brass of Columbia Sportswear, Smarties and Eurazeo.
Weiterlesen »
Everything Jim Cramer said about the stock market on 'Mad Money,' including Apple and Facebook earnings, Wingstop CEO, Spotify and BiogenCNBC's Jim Cramer reveals two things that worries him about affecting tech industry, checks in with Wingstop CEO after its latest quarterly earnings, says Spotify is a buy and makes predictions for Biogen.
Weiterlesen »
Jim Cramer: Investors must consider these two critical factors affecting Facebook and Apple'I'm sensing some skepticism ... creeping in about both of them and I suspect some of it has to do with twin constraints of time and government,' CNBC's Jim Cramer says.
Weiterlesen »
Cramer: This biotech stock could be worth over $100 billion on an FDA approvalBiogen, with a $54.1 billion market cap, 'could be worth twice that if all goes well' with regulators, Jim Cramer says.
Weiterlesen »
Queer Eye goes to Japan: What to expect from the new season on Netflix
Weiterlesen »